The most important financial indicators for the company Nord Pharma S.r.l. - Unique Identification Number 14477809:
sales in 2023 was
961.352
euro, registering a net profit of
276.577
euro and having an average number of
6
employees.
Firma isi desfasoara activitatea in domeniul Comert cu ridicata al produselor farmaceutice having the NACE code 4646.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales increased by 3.0%, from 936.460 euro in the year 2022, to 961.352 euro in 2023.
The Net Profit increased by 46.031 euro, from 231.246 euro in 2022, to 276.577 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Nord Pharma S.r.l. - CUI 14477809
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
243.718
228.082
235.116
215.403
210.367
190.237
168.079
152.805
142.258
224.768
Current Assets
697.185
704.227
723.964
890.464
874.009
695.224
866.454
851.557
612.287
805.823
Inventories
45.475
53.367
59.049
72.212
68.657
66.691
67.416
65.979
89.505
89.448
Receivables
248.593
290.492
306.371
293.702
283.067
280.979
281.021
292.976
398.221
440.695
Cash
403.117
360.368
358.543
524.550
522.286
347.553
518.017
492.602
124.561
275.680
Shareholders Funds
722.164
714.561
166.046
169.866
344.923
550.916
763.148
829.952
603.468
870.503
Social Capital
45
45
45
44
43
42
41
40
41
40
Debts
226.164
226.070
803.442
946.822
749.632
345.215
280.944
183.900
160.517
169.376
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"4646 - 4646"
CAEN Financial Year
4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
805.823 euro in 2023 which includes Inventories of
89.448 euro, Receivables of
440.695 euro and cash availability of
275.680 euro.
The company's Equity was valued at
870.503 euro, while total Liabilities amounted to
169.376 euro.
Equity increased by 268.865 euro, from 603.468 euro in 2022, to 870.503 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Nord Pharma S.r.l.